Highlighting Key Data from the CHERISH and SHINE Studies

Opinion
Video

Longitudinal trends in hospitalization rates in patients with later-onset SMA (SMA) treated with nusinersen up to 4.5 years are discussed. Results from the CHERISH and SHINE studies are discussed.

Recent Videos
Screenshot of an interview with Harmony Garges, MD
George O. Waring, IV, MD, during a video interview
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.